These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6756058)

  • 21. Mechanism of action for N-substituted benzamide-induced apoptosis.
    Olsson AR; Lindgren H; Pero RW; Leanderson T
    Br J Cancer; 2002 Mar; 86(6):971-8. PubMed ID: 11953831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The benzamides: evidence for action at dopamine receptors--shortcomings of current models.
    Wazer DE; Rotrosen J; Stanley M
    Adv Biochem Psychopharmacol; 1982; 35():83-95. PubMed ID: 6756063
    [No Abstract]   [Full Text] [Related]  

  • 23. (E)-(methyloxyimino)acetamides as analogues of neuroleptic benzamides: synthesis and D2-dopaminergic binding affinity.
    Lapucci A; Macchia M; Orlandini E; Romagnoli F; Rossello A; Chiellini G; Cozzini P; Domiano P
    Farmaco; 1996 Jan; 51(1):33-9. PubMed ID: 8721759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic haloperidol and sulpiride treatment on rat nigral GABA content.
    Rampello L; Giammona G; Patti F; Reggio A; Nicoletti F; Di Giorgio RM; Condorelli DF
    Boll Soc Ital Biol Sper; 1981 Aug; 57(15):1608-11. PubMed ID: 7306401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of clebopride on lower esophageal sphincter pressure.
    Ribeiro V; da Silva AL; Castro Lde P
    Arq Gastroenterol; 1981; 18(2):71-4. PubMed ID: 7332503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of neuroleptics on cytotoxic activity of macrophages in rats.
    Madej A; Belowski D; Kowalski J; Herman ZS
    Boll Chim Farm; 1998 May; 137(5):135-9. PubMed ID: 9689898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of metoclopramide, sulpiride, and the stereoisomers of baclofen on amphetamine-induced behavior in the marmoset.
    Ridley RM; Scraggs PR; Baker HF
    Biol Psychiatry; 1980 Apr; 15(2):265-74. PubMed ID: 7191332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trials of benzamides in psychiatry.
    Peselow ED; Stanley M
    Adv Biochem Psychopharmacol; 1982; 35():163-94. PubMed ID: 6756060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral supersensitivity to methamphetamine following chronic treatment with (--)-sulpiride in the rat.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):401-6. PubMed ID: 7195265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [About the action of chlorpromazine].
    CHARDON G
    C R Seances Soc Biol Fil; 1955; 149(15-18):1539-41. PubMed ID: 13305045
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors.
    Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF
    Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667
    [No Abstract]   [Full Text] [Related]  

  • 32. [Action of chlorpromazine on protein metabolism in the neural cell; critico-experimental note].
    BAGGIO G; BORASI M; GOMIRATO G
    Encephale; 1956; 45(4):1162-5. PubMed ID: 13384355
    [No Abstract]   [Full Text] [Related]  

  • 33. Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonists.
    Glase SA; Akunne HC; Georgic LM; Heffner TG; MacKenzie RG; Manley PJ; Pugsley TA; Wise LD
    J Med Chem; 1997 Jun; 40(12):1771-2. PubMed ID: 9191952
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chronic treatment with 1-sulpiride and haloperidol on central dopamine turnover evaluated in dopamine cell body and nerve terminal-rich areas.
    Agnati LF; Andersson K; Fuxe K; Benfenati F; Cortelli P; D'Alessandro R; Ogren SO
    Adv Biochem Psychopharmacol; 1980; 24():75-80. PubMed ID: 7405679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of chlorpromazine and haloperidol on second messenger systems related to adrenergic receptors.
    Nalepa I
    Pol J Pharmacol; 1993; 45(4):399-412. PubMed ID: 8118483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia.
    Pani L; Gessa GL
    Mol Psychiatry; 2002; 7(3):247-53. PubMed ID: 11920152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tourette syndrome: history and present status.
    Shapiro AK; Shapiro E
    Adv Neurol; 1982; 35():17-23. PubMed ID: 6756086
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of chronic treatment with l-sulpiride and haloperidol on central monoaminergic mechanisms.
    Fuxe K; Ogren SO; Hall H; Agnati LF; Andersson K; Köhler C; Schwarcz R
    Adv Biochem Psychopharmacol; 1980; 24():193-206. PubMed ID: 6967676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain.
    Rastogi RB; Lapierre YD; Singhal RL; Nair NP
    Adv Biochem Psychopharmacol; 1980; 24():283-9. PubMed ID: 6996443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.